(EN) Robert Jackson, Serum Sickness, in Journal of Cutaneous Medicine and Surgery, vol. 4, n. 4, 2000-10, pp. 223–225, DOI:10.1177/120347540000400411. URL consultato il 10 agosto 2020.
Karliner JS, Belaval GS., Incidence of reactions following administration of antirabies serum; study of 526 cases., in JAMA., vol. 193, Aug 2 1965, pp. 359-362, PMID14313890.
Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, et al., Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group., in JAMA., vol. 273, n. 12, Mar 1995, pp. 934-41, PMID7884952.
Vial T, Pont J, Pham E, et al., Cefaclor-associated serum sickness-like disease: eight cases and review of the literature., in Ann Pharmacother., vol. 26, n. 7-8, Jul-Aug 1992, pp. 910-914, PMID1504397.
(EN) Robert Jackson, Serum Sickness, in Journal of Cutaneous Medicine and Surgery, vol. 4, n. 4, 2000-10, pp. 223–225, DOI:10.1177/120347540000400411. URL consultato il 10 agosto 2020.